Effectiveness of pain reduction after 5% dextrose perineural injection of axillary nerve in rotator cuff tendinopathy patients

Effectiveness of pain reduction after 5% dextrose perineural injection of proximal versus distal part of axillary nerve in rotator cuff tendinopathy patients with shoulder with arm pain

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200805002

Enrollment

Registered

2020-08-05

Start date

2020-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tendinopathy shoulder pain, rotator cuff tendinopathy, rotator cuff syndrome, perineural injection, dextrose, prolotherapy

Interventions

5% Dextrose 4 ml perineural injection by ultrasound guide of axillary nerve at Quadrilateral space area (Proximal part), 5% Dextrose 4 ml perineural injection by ultrasound guide of axillary nerve at

Experimental Procedure/Surgery,Active Comparator Procedure/Surgery,Sham Comparator Procedure/Surgery

5%dextrose perineural injection at proximal part,5%dextrose perineural injection at distal part,Control group

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis rotator cuff tendinopathy 2. have shoulder with arm pain more than 4 weeks 3. pain was not improved after standard treatment 4. VAS more than 40 mm 5. age 18 - 60 years old 6. willing to participate in research protocol

Exclusion criteria

Exclusion criteria: 1. Massive or full thickness tear of rotator cuff tendon 2. have treated with medication, physical modality or injection intraarticular of shoulder within 1 month prior to participate. 3. have diagnosed of others pathology such as C-spondylosis with radiculopathy, brachial plexopathy or thoracic outlet syndrome 4. have infected skin at the site of injection 5. unexplainable of weakness and sensory loss 6. have received anticoagulant, dual anti-platelet drug or have bleeding disorder 7. have history of systematic rheumatic disease 8. unable to perform dairy activities or follow to exercise precription. 9. pregnancy

Design outcomes

Primary

Measure	Time frame
Pain at shoulder 15 minutes, 2 weeks, 4 weeks Visial analogue scale	—

Secondary

Measure	Time frame
Range of motion of shoulder 15 minutes, 2 weeks, 4 weeks gonitometry,Functional score 4 weeks Oxford sholder score	—

Countries

Thailand

Contacts

Public ContactSuda Pipatbannakij

Faculty of Medicine, Chulalongkorn university

aungsuda24@gmail.com0867890899

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026